Evaluation of the Gum fromHakea gibbosaas a Sustained-Release and Mucoadhesive Component in Buccal Tablets
- 1 January 1999
- journal article
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 4 (3) , 347-358
- https://doi.org/10.1081/pdt-100101370
Abstract
(1999). Evaluation of the Gum from Hakea gibbosa as a Sustained-Release and Mucoadhesive Component in Buccal Tablets. Pharmaceutical Development and Technology: Vol. 4, No. 3, pp. 347-358.Keywords
This publication has 29 references indexed in Scilit:
- Transmucosal Delivery of Oxytocin to Rabbits Using a Mucoadhesive Buccal PatchPharmaceutical Development and Technology, 1997
- Absorption of Thyrotropin-Releasing Hormone in Rats Using a Mucoadhesive Buccal PatchDrug Development and Industrial Pharmacy, 1997
- Enhancement of Bioavailability of Dopamine via Nasal Route in Beagle Dogs.CHEMICAL & PHARMACEUTICAL BULLETIN, 1992
- Transport of Thyrotropin Releasing Hormone in Rabbit Buccal Mucosa in VitroPharmaceutical Research, 1992
- The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers.British Journal of Clinical Pharmacology, 1989
- Buccal/gingival drug delivery systemsJournal of Controlled Release, 1987
- Moment analysis of intravenous, intraduodenal, buccal, rectal and percutaneous nifedipine in rats.Journal of Pharmacobio-Dynamics, 1987
- Topical mucosal adhesive dosage formsMedicinal Research Reviews, 1986
- Bioadhesive Polymers as Platforms for Oral Controlled Drug Delivery II: Synthesis and Evaluation of Some Swelling, Water-Insoluble Bioadhesive PolymersJournal of Pharmaceutical Sciences, 1985
- Powder dosage form of insulin for nasal administrationJournal of Controlled Release, 1984